Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
Background: Lung cancer poses great threat to human health, and lung adenocarcinoma (LUAD) is the main subtype. Immunotherapy has become first line therapy for LUAD. However, the pathogenic mechanism of LUAD is still unclear.Methods: We scored immune-related pathways in LUAD patients using single sa...
Saved in:
Main Authors: | Mengfeng Liu (Author), Qifan Xiao (Author), Xiran Yu (Author), Yujie Zhao (Author), Changfa Qu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma
by: Wei Jiang, et al.
Published: (2023) -
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
by: Yuquan Bai, et al.
Published: (2022) -
Construction of an immunogenic cell death-related LncRNA signature to predict the prognosis of patients with lung adenocarcinoma
by: Shuaishuai Wang, et al.
Published: (2024) -
A Novel Integrated Metabolism-Immunity Gene Expression Model Predicts the Prognosis of Lung Adenocarcinoma Patients
by: Songming Chen, et al.
Published: (2021) -
Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma
by: Zhimin Lin, et al.
Published: (2023)